The report pointed to the COVID-19 pandemic as a market growth driver because of increased digitization creating new opportunities in the market. The U.S. is expected to see the most significant growth within the transcatheter heart valve replacement North American market, according to the Aug. 8 report.
The report used historical market research data from 2015 to 2020 to project the transcatheter heart valve replacement market from 2022 to 2032.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
